What was the nature of the 10,254-share award to Encompass Health (EHC) executive Patrick William Tuer?

The 10,254-share award to Encompass Health (EHC) EVP and COO Patrick William Tuer was a grant or award acquisition at $0.00 per share. A footnote explains it resulted from satisfying performance criteria tied to a performance share unit award made on February 23, 2023.

What does the 3,790-share restricted stock grant to Encompass Health (EHC) COO represent?

The 3,790-share restricted stock grant to Encompass Health (EHC) EVP and COO Patrick William Tuer is described as an annual award. A footnote states it was issued as restricted stock under Encompass Health’s 2025 Omnibus Performance Incentive Plan at a price of $0.00 per share.

Encompass Health (EHC) COO granted 14,044 shares in equity awards

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Encompass Health Corp executive Patrick William Tuer, EVP and Chief Operating Officer, reported acquiring company stock through equity awards. On February 18, 2026, he received 10,254 shares of Encompass Health common stock at a price of $0.00 per share as a grant or award, bringing his direct holdings to 26,296 shares.

On February 19, 2026, he received an additional 3,790 restricted shares at $0.00 per share, increasing his direct ownership to 30,086 shares. Footnotes state that one issuance reflects satisfaction of performance criteria from a February 23, 2023 performance share unit award, and the other is an annual restricted stock award under the 2025 Omnibus Performance Incentive Plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Tuer Patrick William

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Encompass Health Common Stock	3,790	$0.00	--
Grant/Award	Encompass Health Common Stock	10,254	$0.00	--

Holdings After Transaction: Encompass Health Common Stock — 30,086 shares (Direct)

Footnotes (1)

This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

Form 4 Insider Transactions: What Each Field Means →

02/20/2026 - 03:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last)

(First)

(Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM

35242

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/18/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Encompass Health Common Stock	02/18/2026		A		10,254⁽¹⁾	A	$0	26,296	D
Encompass Health Common Stock	02/19/2026		A		3,790⁽²⁾	A	$0	30,086	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023.

2. Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan.

	/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Encompass Health (EHC) report for Patrick William Tuer?

Encompass Health (EHC) reported that EVP and COO Patrick William Tuer acquired company stock through two equity awards. He received 10,254 shares on February 18, 2026, and 3,790 restricted shares on February 19, 2026, both at $0.00 per share.

How many Encompass Health (EHC) shares does Patrick William Tuer own after these Form 4 transactions?

After the reported Form 4 transactions, Patrick William Tuer directly owns 30,086 Encompass Health (EHC) common shares. His holdings rose from 26,296 shares following the 10,254-share award to 30,086 after receiving an additional 3,790 restricted shares the next day.

Were the Encompass Health (EHC) Form 4 transactions open-market purchases or equity awards?

The Encompass Health (EHC) Form 4 transactions were equity awards, not open-market purchases. Both are coded as “A” for grants or other acquisitions at $0.00 per share, tied to performance share unit criteria and the 2025 Omnibus Performance Incentive Plan.